DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pemtumomab
Pemtumomab
(12) United States Patent (10) Patent No.: US 9,161,992 B2 Jefferies Et Al
Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
Perspectives on Cancer Therapy with Radiolabeled Monoclonal Antibodies
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
Treatment of Cancer.Pptx
Translational Research in Surgical Disease
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
Targeted Radionuclide Therapy of Human Tumors
Improving the Efficacy of Antibody-Based Cancer Therapies
Ovarian Cancer
A61K9/51 (2006.01) — with International Search Report (Art
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
Wo 2010/095940 A2
Mai Muita in Acut Ca Uti on Muunni
Humoral Immune Response to Melanoma: Discovery and Evaluation of Anti-Melanoma Antibodies
Assessment of the Evolution of Cancer Treatment Therapies
(12) Patent Application Publication (10) Pub. No.: US 2016/0235842 A1 Goldstein Et Al
Antibody Therapy of Cancer
Top View
Selecting Potential Targetable Biomarkers For
Molecular Targets for Targeted Radionuclide Therapy
(12) United States Patent (10) Patent No.: US 9,345,770 B2 Storkus Et Al
Colorado Cancer Coalition and Task Force Updates
In Oncology Lacey R
Us 2019 / 0202839 A1
Yttrium-90 and Rhenium-188 Radiopharmaceuticals for Radionuclide Therapy
WO 2013/119960 A2 15 August 2013 (15.08.2013) P O P C T
Dihydropyrrolidino-Pyrimidines As Kinase Inhibitors Dihydropyrrolidinpyrimidine Als Kinaseinhibitoren Dihydropyrrolidinopyrimidines Comme Inhibiteurs De Kinase
Ep 3088005 A1
Assessment of the Evolution of Cancer Treatment Therapies
CAPTURE Study 2089
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al
Human BMPR1B Amino Acid Sequence